Who
In numbers
- Trades disclosed
- 20
- Buys
- 1
- Sells
- 0
- Bought
- $300K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 30 Apr 2020
- Last trade
- 6 Jul 2026
- Last filed
- 7 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month. 1 lines have no legible date and are left out.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jul 2026filed 7 Jul 2026 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 11 Oct 2024filed 16 Oct 2024 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —829 at $0.00 | filing |
| —filed 5 Sep 2024 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 | filing |
| 3 Sep 2024filed 5 Sep 2024 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $150K50,000 at $3.00 | filing |
| 18 Oct 2023filed 19 Oct 2023 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,434 at $0.00 | filing |
| 23 Jun 2023filed 26 Jun 2023 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $150K64,212 at $2.34 | filing |
| 16 Dec 2022filed 19 Dec 2022 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $250K148,809 at $1.68 | filing |
| 10 Jun 2022filed 30 Sep 2022 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,434 at $0.00 | filing |
| 15 Jun 2021filed 15 Jun 2021 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,434 at $0.00 | filing |
| 31 Mar 2021filed 7 Apr 2021 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | —2,520 at $0.00 | filing |
| 31 Dec 2020filed 5 Jan 2021 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | —2,800 at $0.00 | filing |
| 31 Dec 2020filed 5 Jan 2021 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | —2,734 at $0.00 | filing |
| 30 Sep 2020filed 9 Oct 2020 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | —2,734 at $0.00 | filing |
| 30 Jun 2020filed 1 Jul 2020 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | —2,734 at $0.00 | filing |
| 19 Jun 2020filed 23 Jun 2020 | BCDA BioCardiaBiotechnology | SEC FORM 4 Bought | $300K142,850 at $2.10 | filing |
| 8 May 2020filed 20 May 2020 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | —4,100 at $0.00 | filing |
| 30 Apr 2020filed 4 May 2020 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | —2,187 at $0.00 | filing |
| 30 Apr 2020filed 4 May 2020 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | —2,734 at $0.00 | filing |
News
BioCardia Advances Helix Catheter Toward FDA Marketing ClearanceBCDA · rttnews.com · 19 Oct 2026
0 headlines in the last 90 days name Jim L. Allen; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.